Markets
    IPOs

    Sinotau Opens HK$446 Million Hong Kong IPO After Amicro, Hosin Debuts Diverge

    Amicro opened 37.6% above its offer price on Thursday while Hosin opened just below it, as radiopharmaceutical developer Sinotau tests demand for a small deal.

    Share on X LinkedIn WhatsApp
    The HKEX entrance at Exchange Square in Central, Hong Kong
    The HKEX entrance at Exchange Square, Hong Kong Photo: YaEeBondZ 002 via Wikimedia Commons, CC0

    What to know

    • HOSIN Electronics raised HK$1.07 billion at HK$72.83 a share and opened at HK$72.80 on its Nov. 12 debut; etnet's delayed quotes showed it at HK$69.45 shortly before 1 p.m. on Monday.
    • Amicro Technology, which raised HK$709.7 million at HK$9.90 after a 13.95-times subscribed retail tranche, opened 37.6% higher on debut; etnet showed it at HK$11.67 on Monday.
    • Beijing Sinotau opened books on Nov. 16 for 6.56 million H shares at HK$52 to HK$68 each, with trading set to start Nov. 24.

    HONG KONG

    Beijing Sinotau International Pharmaceutical Technology, a loss-making radiopharmaceutical developer, opened books on Monday for a Hong Kong initial public offering of up to HK$446 million, days after two Chinese chip companies had sharply different debuts. On Thursday, Nov. 12, robotics chip designer Amicro Technology opened 37.6% above its HK$9.90 offer price, while memory and storage maker HOSIN Electronics opened a fraction below its HK$72.83 price, The Standard reported.

    The gap has persisted. Etnet's 15-minute delayed quotes shortly before 1 p.m. on Monday showed Amicro at HK$11.67, about 18% above its offer price, and Hosin at HK$69.45, below its listing price. Both companies had priced in the lower half of their marketed ranges. For investors in Hong Kong's crowded new-issue market, the three deals show how much first-week returns now depend on the size of the retail book and on how tightly the shares are held.

    Hosin and Amicro priced low, then diverged

    Hosin sold 14.72 million H shares at HK$72.83, raising gross proceeds of HK$1.07 billion, according to its allotment announcement; etnet's listing page shows a marketed range of HK$72.29 to HK$82.90. The Hong Kong retail tranche was 2.37 times subscribed and the international tranche 1.45 times covered, with 63 placees. Every one of the 4,625 valid retail applications received shares.

    Seven cornerstone investors, including Transsion International and Longsys Investment, took 42.08% of the offer shares. The company sold only a small slice of its capital: 482.5 million shares were in issue on listing. Its allotment notice carried a formal warning that the stock's ownership is highly concentrated, so the price "could move substantially" even on thin trading.

    On debut day, Hosin opened at HK$72.80, a hair under its offer price, and last traded at HK$72.90 at the time of The Standard's report. Etnet's quote page on Monday showed the shares down 3.07% on the day and flagged them as trading below the listing price.

    Amicro, which develops intelligent mobile robotics solutions and plans to spend most of its proceeds on software, hardware and AI chips for robots, according to The Standard, priced its 71.69 million shares at HK$9.90, near the bottom of the HK$9.27 to HK$11.58 range shown on etnet, for gross proceeds of HK$709.7 million. Retail demand was much stronger than at Hosin: the public tranche was 13.95 times subscribed, which triggered a claw-back that doubled the retail allocation to about 10% of the deal. The international book was only 1.05 times covered, and the largest single placee took 25 million shares, or 38.7% of the international offering, according to the filing.

    The stock opened at HK$13.62, up 37.6%, and changed hands at HK$16.81 later in the debut session, The Standard reported. By Monday it had given back much of that move: etnet's midday quote showed it down 1.5% on the day at HK$11.67, still well above the offer price. Amicro's two cornerstone investors, Digital Horizon and Compro Lighting, are locked up until May 11, 2027.

    Capital Times has covered how recent Hong Kong listings have traded against their offer prices and the Denglin Technology offering.

    Sinotau tests demand for a small radiopharmaceutical deal

    Sinotau opened its Hong Kong public offering at 9 a.m. on Monday. It is selling 6.56 million H shares at HK$52 to HK$68 each, which would raise HK$341 million to HK$446 million before the over-allotment option, according to its formal notice. Retail investors get 656,100 shares, or 10% of the deal, which can rise to 15% if demand is strong. Books close at noon on Thursday, Nov. 19, the price is due by noon on Friday, Nov. 20, and trading is scheduled to begin on Tuesday, Nov. 24, under stock code 9941. The sponsors are GF Capital, China International Capital Corp. and CITIC Securities, etnet's listing page shows.

    The prospectus values the company at HK$3.41 billion to HK$4.46 billion at the bottom and top of the range. Unlike Hosin and Amicro, the offering does not name any cornerstone investors in its offering structure.

    Founded in 2005, Sinotau develops radioactive drugs for both diagnosis and treatment in cancer, neurodegenerative and heart disease. Its lead product, XTR008, is a radioligand for neuroendocrine tumors that the company describes as a generic version of the drug Lutathera. The prospectus says approval from China's drug regulator is expected in December 2026.

    The numbers show a company still far from profit. Revenue rose to 99.2 million yuan in 2025 from 44.1 million yuan in 2024, helped by sales of an Alzheimer's imaging agent, XTR005, and reached 61.3 million yuan in the first half of 2026. The net loss widened to 618.4 million yuan in 2025 and 533.9 million yuan in the first six months of this year. The company attributed much of the increase to fair-value losses on redemption rights attached to shares held by pre-IPO investors, which accounted for 309.8 million yuan of the first-half loss.

    At the midpoint price of HK$60, Sinotau expects net proceeds of about HK$329.1 million. It plans to spend 88% of that, or roughly HK$289.5 million, on research, development and registration filings for its two core products, XTR008 and XTR004.

    What to watch this week

    The size of Sinotau's retail book will be the first signal. Its board lot is just 50 shares, costing HK$3,434.29 including fees at the top of the range, which keeps the entry price low for small investors. Results of the allocation, including the final price and subscription levels, are due by 11 p.m. on Monday, Nov. 23, the night before trading begins.

    For Hosin, the next marker is its stabilization period. The company over-allocated 2.21 million shares, and its stabilizing manager may buy shares in the market at or below the HK$72.83 offer price to cover that position. Whether it does, and how many of the over-allotment shares the company ends up issuing, will be disclosed after the stabilization period expires on Wednesday, Dec. 9.

    Sources

    1. The Standard: Chinese chip firms Hosin, Amicro rise in Hong Kong debuts (Nov. 12, 2026)
    2. HKEXnews: HOSIN Electronics Co., Ltd.: Announcement of Final Offer Price and Allotment Results (Nov. 11, 2026)
    3. HKEXnews: Amicro Technology Co., Ltd.: Announcement of Final Offer Price and Allotment Results (Nov. 11, 2026)
    4. HKEXnews: Beijing Sinotau International Pharmaceutical Technology Co., Ltd.: Global Offering (formal notice) (Nov. 16, 2026)
    5. HKEXnews: Beijing Sinotau International Pharmaceutical Technology Co., Ltd.: Prospectus (Nov. 16, 2026)
    6. etnet: IPO Detail: HOSIN ELEC (02681) (Nov. 16, 2026)
    7. etnet: IPO Detail: AMICRO (02065) (Nov. 16, 2026)
    8. etnet: IPO Detail: SINOTAUPHARMA-B (09941) (Nov. 16, 2026)

    Capital Times Staff

    Capital Times newsroom, Hong Kong, Singapore and Jakarta

    Capital Times covers markets, business and economies across Asia.

    newsroom@capitaltimes.asia

    Our standards: Capital Times reports under the principles set out in our Editorial Standards and Ethics Policy. Spotted an error? Report it to our editors.

    Markets Data

    Hong Kong ClosedShanghai ClosedTokyo ClosedSeoul ClosedSingapore ClosedJakarta ClosedSydney ClosedMumbai Closed